727 
The Role of Immune Reconstitution in the Onset of Subclinical Atheromasic Lesions
Paolo Maggi*1, F Perilli2, A Lillo2, A Volpe1, C Bellacosa1, G Pastore1, and G Regina2
1Clinica delle Malattie Infettive - Universitą degli Studi di Bari and 2Cattedra di Chirurgia Vascolare - Universitą degli Studi di Bari
Background: In recent studies
(SMART, MACS, WIHS) patients with low CD4+ cell count showed an increased
risk for cardiovascular disease (CVD). Hyper-production of pro-inflammatory cytokines
(interleukin-6, highly sensitive C-reactive protein) has
been hypothesized in these patients. No data exist regarding the role of immune
reconstitution in the onset of CVD, another condition that could be related to
an increase of circulating pro-inflammatory factors. In the present study we
evaluated 263 patients starting ART at baseline and after 12 months, with
color Doppler ultrasonograpy of the epiaortic vessels, a well-validated
technique, considered the gold standard for the detection of premature vascular
lesions.
Methods: Patients were submitted to color Doppler
ultrasonography at baseline and after 12 months of therapy. An intima media thickness
>0.9 mm or atherosclerotic plaques was considered a pathologic finding. After 12 months of ART, patients with <50 CD4+ cell
count/mm3 at baseline were divided into 3 groups based on CD4+
at follow-up: A) patients with <100 CD4+ (n = 41); B) patients
with 100 to 199 CD4+ (n = 50), and C) patients with >200 CD4+
(n = 62). The data were compared with those observed in 110 patients starting
ART with >200 CD4+ and remaining at follow-up, over this value (group
D).The 4 groups were comparable for gender, mean age, and other risk factors
for CVD. ARV drugs were well balanced among the groups.
Results:
|
Group
|
Patients with carotid lesions
|
|
baseline
|
follow up
|
|
|
%
|
#
|
%
|
#
|
|
|
A
|
26.8
|
11
|
41.6
|
17
|
p = 0.27
|
|
B
|
28.0
|
14
|
42.0
|
21
|
p = 0.14
|
|
C
|
27.4
|
17
|
61,2
|
38
|
p = 0.0001
|
|
D
|
18.1
|
24
|
24.7
|
25
|
p = 0.71
|
As showed in the table, patients with <50
CD4+ cell count at baseline who reached values >100 (group C)
showed a significant increase in the number of carotid lesions at follow-up. Moreover,
comparing patients with <50 cells at baseline (groups A+B+C) with patients
with >200 cells (group D), the first group had a significant increase of
lesions with respect to group D.
Conclusions: These data show that patients starting
ARV with a high degree of immune depression tend to develop more lesions than patients
starting ARV in a relatively better immunologic conditions. Moreover, patients
experiencing more rapid immune reconstitution develop a significantly higher
number of subclinical vascular lesions. This suggests that inflammatory events
characterizing both immune deficiency and immune reconstitution could play a
role in the onset of CVD.
|